CDC

Below you find a Compendium of Heaton k.s.’s products marketed in the Czech Republic. The Compendium includes information’s in electronic form on medicinal products that are subject to medical prescription. We believe that this information allows easy and fast access to general information of our products.

Public scientific service includes information about Heaton’s products registered in the Czech Republic.

Obligation to establish Public scientific service is specified in Act No. 378/2007 Coll. on drugs and Changes and Amendments to Some Related Acts). These websites are in harmony with rules for accessible web according amendment to the Act 365/2000 Coll.; websites meet the requirements of methodologies “The rules for creating accessible web”.


For more information, please contact us at:
Heaton k.s., Na Pankráci 14, 140 00 Praha 4
e-mail: safety@heaton.cz
tel.: +420 242 428 690


 

Available
Unavailable

Gynecology

SUNYA

Per oral hormonal contraception

Package leaflet
Education materials

KATYA

Per oral hormonal contraception

Package leaflet
Education materials

EBELYA

Per oral hormonal contraception

Package leaflet

NELYA

Per oral hormonal contraception

Package leaflet
Education materials

LUISEA

Per oral hormonal contraception

Package leaflet
Education materials

SIRMYA

Per oral hormonal contraception.
In Finland/Denmark available under brand name Yanulez/Yana.

Package leaflet
Education materials

ADELE

Per oral hormonal contraception

Package leaflet
Education materials

VREYA

Treatment of acne, seborrhoea or mild or hirsutism in women in fertility age in cases with necessity of hormonal treatment

Package leaflet

FLAYA

Per oral hormonal contraception

Package leaflet
Education materials

NATALYA

Per oral hormonal contraception

Package leaflet
Education materials

TEYLA

Vaginal contraceptive system

Package leaflet
Education materials

LAMYA

Per oral hormonal contraception

Package leaflet

Urology

DERIDUST

Treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH)

Package leaflet

ZABCARE

Symptomatic treatment of urge incontinence in adults with overactive bladder

Package leaflet

Nefrology

ALFACALCIDOL

Alfacalcidol is indicated for conditions associated with impaired calcium metabolism

Package leaflet
Education materials

CINACALCET

For the treatment of secondary hyperparathyroidism

Package leaflet

REXTOL 5MCG/ML

Prevetion and treatment of secondary hyperparathyroidism (HPT) in adult patients with end-stage renal disease (ESRD) who are on haemodialysis

SEVELAMER CARBONATE HEATON 800MG

To treat hyperphosphataemia in adult patients receiving hemodialysis or peritoneal dialysis or for not dialysis adult patients

Package leaflet
Education materials

Oncology

ERLOTINIB

It is indicated as a first-line treatment in patients with bronchopulmonary neoplasm.

Prospect

BORTEGA

Treatment of adults with multiple myeloma

Package leaflet

LERANA

Treatment of breast cancer

Package leaflet

ANAYA

Treatment of breast cancer

Package leaflet

Hospital segment

GECROL

Prophylaxis and treatment of transplant rejection in allograft recipients

Package leaflet

TAZIP

Antibiotic for treatment of severe life-treating states

Package leaflet

Other areas

RAVATA

Substitution treatment for opioid drug dependence within a framework of medical, social and psychological treatment

Package leaflet